Kodiak Sciences, Inc. (KOD)
107.95
+0.85
(+0.79%)
USD |
NASDAQ |
Nov 10, 16:00
107.95
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Cash from Operations (Annual) : -136.01M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -136.01M |
| December 31, 2024 | -117.32M |
| December 31, 2023 | -154.18M |
| December 31, 2022 | -206.46M |
| December 31, 2021 | -182.27M |
| Date | Value |
|---|---|
| December 31, 2020 | -83.43M |
| December 31, 2019 | -39.15M |
| December 31, 2018 | -29.03M |
| December 31, 2017 | -17.66M |
| December 31, 2016 | -16.05M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| AbbVie, Inc. | 19.03B |
| Mirum Pharmaceuticals, Inc. | 55.83M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |